Why the study?
Can heart rate variability be used as a screening method for iron overload cardiomyopathy in transfusion-dependent thalassemia patients?
Population
Patients with transfusion-dependent thalassemia (TDT)
Comparison
Heart rate variability evaluated by 24-h Holter… vs Patients without a cardiac iron overload condition
Design
Cross-sectional
Authors
Loading...
HRV LF/HF ratio was associated with CMR-T2* and LVEF; leaves open its utility for screening iron overload cardiomyopathy pending prospective validation.
Can heart rate variability be used as a screening method for iron overload cardiomyopathy in transfusion-dependent thalassemia patients?
Heart rate variability, specifically the LF/HF ratio, correlates with CMR-T2* and LVEF, suggesting it may serve as an accessible early screening tool for cardiac iron overload in transfusion-dependent thalassemia patients.
Pattanakuhar et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: